{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "17429947", "DateCompleted": {"Year": "2007", "Month": "05", "Day": "31"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [{"Year": "2007", "Month": "04", "Day": "13"}], "Journal": {"ISSN": "0006-2960", "JournalIssue": {"Volume": "46", "Issue": "18", "PubDate": {"Year": "2007", "Month": "May", "Day": "08"}}, "Title": "Biochemistry", "ISOAbbreviation": "Biochemistry"}, "ArticleTitle": "Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.", "Pagination": {"StartPage": "5552", "EndPage": "5561", "MedlinePgn": "5552-61"}, "Abstract": {"AbstractText": ["Apolipoprotein amyloid deposits and lipid oxidation products are colocalized in human atherosclerotic tissue. In this study we show that the primary ozonolysis product of cholesterol, 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al (KA), rapidly promotes human apolipoprotein (apo) C-II amyloid fibril formation in vitro. Previous studies show that hydrophobic aldehydes, including KA, modify proteins by the formation of a Schiff base with the lysine epsilon-amino group or N-terminal amino group. High-performance liquid chromatography, mass spectrometry, and proteolysis of KA-modified apoC-II revealed that KA randomly modified six different lysine residues, with primarily one KA attached per apoC-II molecule. Competition experiments showed that an aldehyde scavenging compound partially inhibited the ability of KA to hasten apoC-II fibril formation. Conversely, the acid derivative of KA, lacking the ability to form a Schiff base, accelerated apoC-II fibril formation, albeit to a lesser extent, suggesting that amyloidogenesis triggered by KA involves both covalent and noncovalent mechanisms. The viability of a noncovalent mechanism mediated by KA has been observed previously with alpha-synuclein aggregation, implicated in Parkinson's disease. Electron microscopy demonstrated that fibrils formed in the presence of KA had a similar morphology to native fibrils; however, the isolated KA-apoC-II covalent adducts in the absence of unmodified apoC-II formed fibrillar structures with altered ropelike morphologies. KA-mediated fibril formation by apoC-II was inhibited by the addition of the amine-containing compound hydralazine and the lipid-binding protein apoA-I. These in vitro studies suggest that the oxidized small molecule pool could trigger or hasten the aggregation of apoC-II to form amyloid deposits."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia."}], "Identifier": [], "LastName": "Stewart", "ForeName": "Cameron R", "Initials": "CR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wilson", "ForeName": "Leanne M", "Initials": "LM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Qinghai", "Initials": "Q"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pham", "ForeName": "Chi L L", "Initials": "CL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Waddington", "ForeName": "Lynne J", "Initials": "LJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Staples", "ForeName": "Maree K", "Initials": "MK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Stapleton", "ForeName": "David", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kelly", "ForeName": "Jeffery W", "Initials": "JW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Howlett", "ForeName": "Geoffrey J", "Initials": "GJ"}], "GrantList": [{"GrantID": "NS 50636", "Acronym": "NS", "Agency": "NINDS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biochemistry", "NlmUniqueID": "0370623", "ISSNLinking": "0006-2960"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid"}, {"RegistryNumber": "0", "NameOfSubstance": "Apolipoprotein C-II"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipoproteins, LDL"}, {"RegistryNumber": "0", "NameOfSubstance": "oxidized low density lipoprotein"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": ["biosynthesis", "ultrastructure"], "DescriptorName": "Amyloid"}, {"QualifierName": ["chemistry", "metabolism", "ultrastructure"], "DescriptorName": "Apolipoprotein C-II"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Atherosclerosis"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Cholesterol"}, {"QualifierName": [], "DescriptorName": "Circular Dichroism"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Lipoproteins, LDL"}, {"QualifierName": [], "DescriptorName": "Molecular Sequence Data"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "4", "Day": "14", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "6", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "4", "Day": "14", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17429947", "10.1021/bi602554z"]}}], "PubmedBookArticle": []}